Industry Reports
Pfizer expands gene therapy operations with acquisition of Bamboo...
Pfizer Inc announced that it has acquired Bamboo Therapeutics, Inc., a privately held biotechnology company based in Chapel Hill, N.C., focused on developing gene therapies...
Industry Reports
Momenta Pharmaceuticals Reports Second Quarter 2016 Financial Results
Momenta Pharmaceuticals, Inc reported its financial results for the second quarter ended June 30, 2016.For the second quarter of 2016, the Company reported total revenues...
Industry Reports
Boehringer Ingelheim: Growth in all core businesses
Boehringer Ingelheim reported currency-adjusted growth in all its core businesses in the first half of 2016. At the same time, the research-driven pharmaceutical company achieved...
Industry Reports
GSK announced the second quarter 2016 and half-yearly financial...
GSK delivers further progress against strategy with strong Q2 performance Group sales £6.5 billion, +4% CER, with growth across all three businesses ...
Industry Reports
Merck Announces Fourth-Quarter 2016 Dividend
Merck known as MSD outside the United States and Canada announced that the Board of Directors has declared a quarterly dividend of $0.46 per share...
Industry Reports
Novartis Q2 results enhance future growth prospects with eight...
Gilenya (USD 811 million, +17% cc) continued to grow double-digit mainly due to volume growth Cosentyx (USD 260 million) grew strongly driven by its...
Industry Reports
Gilead Sciences to Release Second Quarter 2016 Financial Results...
Gilead Sciences, Inc  announced that its second quarter 2016 financial results will be released on Monday, July 25, after the market closes. At 4:30 p.m....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.